These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8559651)

  • 21. Antiviral activity of RNA molecules containing self-releasing ribozymes targeted to lymphocytic choriomeningitis virus.
    Xing Z; Mahadeviah S; Whitton JL
    Antisense Res Dev; 1995; 5(3):203-12. PubMed ID: 8785476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct requirements for primary sequence in the 5'- and 3'-part of a bulge in the hepatitis B virus RNA encapsidation signal revealed by a combined in vivo selection/in vitro amplification system.
    Rieger A; Nassal M
    Nucleic Acids Res; 1995 Oct; 23(19):3909-15. PubMed ID: 7479035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracellular application of hairpin ribozyme genes against hepatitis B virus.
    Welch PJ; Tritz R; Yei S; Barber J; Yu M
    Gene Ther; 1997 Jul; 4(7):736-43. PubMed ID: 9282175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of hammerhead ribozymes by retroviral vectors to inhibit HIV-1 replication: comparison of RNA levels and viral inhibition.
    Zhou C; Bahner I; Rossi JJ; Kohn DB
    Antisense Nucleic Acid Drug Dev; 1996; 6(1):17-24. PubMed ID: 8783792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Investigation on activities of hammerhead ribozyme embedded in genomic RNA of hepatitis delta virus].
    Li XJ; Kuang ES; Dai W; Yang FH; Wang M; Wang HS; Zhou BP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Mar; 19(1):12-5. PubMed ID: 16201462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hammerhead ribozyme-mediated inhibition of hepatitis B virus X gene expression in cultured cells.
    Weinberg M; Passman M; Kew M; Arbuthnot P
    J Hepatol; 2000 Jul; 33(1):142-51. PubMed ID: 10905598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and preparation of a multimeric self-cleaving hammerhead ribozyme.
    Ruiz J; Wu CH; Ito Y; Wu GY
    Biotechniques; 1997 Feb; 22(2):338-45. PubMed ID: 9043708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cleavage of full-length beta APP mRNA by hammerhead ribozymes.
    Denman RB
    Nucleic Acids Res; 1993 Aug; 21(17):4119-25. PubMed ID: 8371986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ribozyme mediated destruction of influenza A virus in vitro and in vivo.
    Tang XB; Hobom G; Luo D
    J Med Virol; 1994 Apr; 42(4):385-95. PubMed ID: 8046429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional characterization of ribozymes expressed using U1 and T7 vectors for the intracellular cleavage of ANF mRNA.
    De Young MB; Kincade-Denker J; Boehm CA; Riek RP; Mamone JA; McSwiggen JA; Graham RM
    Biochemistry; 1994 Oct; 33(40):12127-38. PubMed ID: 7918434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ribozyme-mediated suppression of Moloney murine leukemia virus and human immunodeficiency virus type I replication in permissive cell lines.
    Sun LQ; Warrilow D; Wang L; Witherington C; Macpherson J; Symonds G
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9715-9. PubMed ID: 7937878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and mode of action of hammerhead and hairpin ribozymes against various HIV-1 target sites.
    Hotchkiss G; Maijgren-Steffensson C; Ahrlund-Richter L
    Mol Ther; 2004 Jul; 10(1):172-80. PubMed ID: 15233952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for multiple distinct interactions between hepatitis B virus P protein and its cognate RNA encapsidation signal during initiation of reverse transcription.
    Feng H; Chen P; Zhao F; Nassal M; Hu K
    PLoS One; 2013; 8(8):e72798. PubMed ID: 23977352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of viral multiplication in acute and chronic stages of infection by ribozymes targeted against the polymerase gene of mouse hepatitis virus.
    Maeda A; Mizutani T; Hayashi M; Ishida K; Watanabe T; Namioka S
    Adv Exp Med Biol; 1995; 380():399-404. PubMed ID: 8830515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of viral multiplication by hammerhead ribozymes targeted against the polymerase gene of mouse hepatitis virus.
    Maeda A; Mizutani T; Hayashi M; Watanabe T; Namioka S
    J Vet Med Sci; 1994 Oct; 56(5):939-45. PubMed ID: 7532438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hammerhead ribozymes targeted to the FBN1 mRNA can discriminate a single base mismatch between ribozyme and target.
    Phylactou LA; Tsipouras P; Kilpatrick MW
    Biochem Biophys Res Commun; 1998 Aug; 249(3):804-10. PubMed ID: 9731217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Examination of the catalytic fitness of the hammerhead ribozyme by in vitro selection.
    Tang J; Breaker RR
    RNA; 1997 Aug; 3(8):914-25. PubMed ID: 9257650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors altering ribozyme-mediated cleavage of tumor necrosis factor-alpha mRNA in vitro.
    Kisich KO; Freedland SJ; Erickson KL
    Biochem Biophys Res Commun; 1997 Jul; 236(1):205-11. PubMed ID: 9223453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The packaging signal in hepatitis B virus pregenome functions only at the 5' end.
    Kawamoto S; Ueda K; Mita E; Matsubara K
    J Virol Methods; 1994 Sep; 49(2):113-27. PubMed ID: 7822453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multifunctional expression vector for an anti-HIV-1 ribozyme that produces a 5'- and 3'-trimmed trans-acting ribozyme, targeted against HIV-1 RNA, and cis-acting ribozymes that are designed to bind to and thereby sequester trans-activator proteins such as Tat and Rev.
    Yuyama N; Ohkawa J; Koguma T; Shirai M; Taira K
    Nucleic Acids Res; 1994 Nov; 22(23):5060-7. PubMed ID: 7800500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.